Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota. more
Time Frame | INSP | Sector | S&P500 |
---|---|---|---|
1-Week Return | 0.68% | -3.39% | 0.2% |
1-Month Return | 8.8% | -1.92% | 2.72% |
3-Month Return | -7.74% | -10.54% | 7.31% |
6-Month Return | 16.52% | -4.47% | 10.44% |
1-Year Return | 1.39% | 4.06% | 27.53% |
3-Year Return | -10.75% | 0.94% | 30.88% |
5-Year Return | 172.6% | 36.67% | 89.21% |
10-Year Return | 663.45% | 102.87% | 199.95% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 82.05M | 115.38M | 233.39M | 407.86M | 624.80M | [{"date":"2019-12-31","value":13.13,"profit":true},{"date":"2020-12-31","value":18.47,"profit":true},{"date":"2021-12-31","value":37.36,"profit":true},{"date":"2022-12-31","value":65.28,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 13.64M | 17.62M | 33.28M | 66.11M | 96.58M | [{"date":"2019-12-31","value":14.13,"profit":true},{"date":"2020-12-31","value":18.25,"profit":true},{"date":"2021-12-31","value":34.46,"profit":true},{"date":"2022-12-31","value":68.46,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 68.41M | 97.76M | 200.12M | 341.74M | 528.22M | [{"date":"2019-12-31","value":12.95,"profit":true},{"date":"2020-12-31","value":18.51,"profit":true},{"date":"2021-12-31","value":37.88,"profit":true},{"date":"2022-12-31","value":64.7,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 83.37% | 84.73% | 85.74% | 83.79% | 84.54% | [{"date":"2019-12-31","value":97.24,"profit":true},{"date":"2020-12-31","value":98.82,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":97.72,"profit":true},{"date":"2023-12-31","value":98.6,"profit":true}] |
Operating Expenses | 103.30M | 153.97M | 239.97M | 389.33M | 568.49M | [{"date":"2019-12-31","value":18.17,"profit":true},{"date":"2020-12-31","value":27.08,"profit":true},{"date":"2021-12-31","value":42.21,"profit":true},{"date":"2022-12-31","value":68.48,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (34.90M) | (56.21M) | (39.85M) | (47.59M) | (40.27M) | [{"date":"2019-12-31","value":-3489700000,"profit":false},{"date":"2020-12-31","value":-5620800000,"profit":false},{"date":"2021-12-31","value":-3985000000,"profit":false},{"date":"2022-12-31","value":-4759200000,"profit":false},{"date":"2023-12-31","value":-4027100000,"profit":false}] |
Total Non-Operating Income/Expense | 3.38M | (1.91M) | (4.12M) | 6.70M | 38.42M | [{"date":"2019-12-31","value":8.79,"profit":true},{"date":"2020-12-31","value":-4.96,"profit":false},{"date":"2021-12-31","value":-10.73,"profit":false},{"date":"2022-12-31","value":17.43,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | (33.20M) | (57.09M) | (41.97M) | (44.27M) | (19.91M) | [{"date":"2019-12-31","value":-3320300000,"profit":false},{"date":"2020-12-31","value":-5708800000,"profit":false},{"date":"2021-12-31","value":-4197000000,"profit":false},{"date":"2022-12-31","value":-4426800000,"profit":false},{"date":"2023-12-31","value":-1990600000,"profit":false}] |
Income Taxes | 40.00K | 115.00K | 72.00K | 613.00K | 1.25M | [{"date":"2019-12-31","value":3.21,"profit":true},{"date":"2020-12-31","value":9.22,"profit":true},{"date":"2021-12-31","value":5.77,"profit":true},{"date":"2022-12-31","value":49.16,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income After Taxes | (33.24M) | (57.20M) | (42.04M) | (44.88M) | (21.15M) | [{"date":"2019-12-31","value":-3324300000,"profit":false},{"date":"2020-12-31","value":-5720300000,"profit":false},{"date":"2021-12-31","value":-4204200000,"profit":false},{"date":"2022-12-31","value":-4488100000,"profit":false},{"date":"2023-12-31","value":-2115300000,"profit":false}] |
Income From Continuous Operations | (33.24M) | (57.20M) | (42.04M) | (44.88M) | (32.77M) | [{"date":"2019-12-31","value":-3324300000,"profit":false},{"date":"2020-12-31","value":-5720300000,"profit":false},{"date":"2021-12-31","value":-4204200000,"profit":false},{"date":"2022-12-31","value":-4488100000,"profit":false},{"date":"2023-12-31","value":-3276600000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (33.24M) | (57.20M) | (42.04M) | (44.88M) | (21.15M) | [{"date":"2019-12-31","value":-3324300000,"profit":false},{"date":"2020-12-31","value":-5720300000,"profit":false},{"date":"2021-12-31","value":-4204200000,"profit":false},{"date":"2022-12-31","value":-4488100000,"profit":false},{"date":"2023-12-31","value":-2115300000,"profit":false}] |
EPS (Diluted) | (1.39) | (2.22) | (1.55) | (1.64) | (0.74) | [{"date":"2019-12-31","value":-139,"profit":false},{"date":"2020-12-31","value":-222,"profit":false},{"date":"2021-12-31","value":-155,"profit":false},{"date":"2022-12-31","value":-164,"profit":false},{"date":"2023-12-31","value":-74,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
INSP | |
---|---|
Cash Ratio | 5.53 |
Current Ratio | 7.84 |
Quick Ratio | 6.94 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
INSP | |
---|---|
ROA (LTM) | 1.18% |
ROE (LTM) | 5.33% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
INSP | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.13 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.87 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
INSP | |
---|---|
Trailing PE | 171.81 |
Forward PE | 102.04 |
P/S (TTM) | 7.56 |
P/B | 8.12 |
Price/FCF | 129 |
EV/R | 6.98 |
EV/Ebitda | 136.08 |
Inspire Medical Systems Inc (INSP) share price today is $194.566
Yes, Indians can buy shares of Inspire Medical Systems Inc (INSP) on Vested. To buy Inspire Medical Systems Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in INSP stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Inspire Medical Systems Inc (INSP) via the Vested app. You can start investing in Inspire Medical Systems Inc (INSP) with a minimum investment of $1.
You can invest in shares of Inspire Medical Systems Inc (INSP) via Vested in three simple steps:
The 52-week high price of Inspire Medical Systems Inc (INSP) is $257.4. The 52-week low price of Inspire Medical Systems Inc (INSP) is $123.
The price-to-earnings (P/E) ratio of Inspire Medical Systems Inc (INSP) is 171.8108
The price-to-book (P/B) ratio of Inspire Medical Systems Inc (INSP) is 8.12
The dividend yield of Inspire Medical Systems Inc (INSP) is 0.00%
The market capitalization of Inspire Medical Systems Inc (INSP) is $5.71B
The stock symbol (or ticker) of Inspire Medical Systems Inc is INSP